7 employees
NextVivo is a biotech company developing an immune organoid technology platform.
2021
$7.9M
from 2 investors over 2 rounds
NextVivo raised $7.9M on December 9, 2021
Investors: Wilson Sonsini Goodrich & Rosati and Khosla Ventures